Sentry Logistic Solutions launched its services and the opening of its $8 million, 53,000-sq.-ft. facility designed for cold chain logistics, storage and packing of bulk pharmaceutical and biotechnology components and finished products.

"Sentry's service launch comes at a time when the life science industry is booming," said Jennifer Marcum, Sentry's chief executive officer. "The company was founded to fill a gap in this growing market by providing storage and logistics services expressly for pharmaceutical and biotech developers and manufacturers. Outsourcing these functions is a cost-effective alternative that allows biopharma firms to focus their Resources on R&D. And, partnering with an industry specialist like Sentry is a safer, more secure option than trusting valuable biopharmaceutical components to vendors that are only marginally familiar with the controlled temperatures and security measures these materials require."

The company specializes in storing and shipping temperature-sensitive materials such as APIs, bulk drug substances (BDS), intermediates, components, finished drug products and pharmaceutical components. The company also stores equipment and primary and secondary packaging materials. The warehouse and logistics center is classified as a Highly Protected Risk (HPR) facility and the company's processes, systems and technologies are validated according to FDA regulations.